Member Info for Mars1

Govt carrying out live gig LFT tests, Liverpool rave has to be a great success having found 500 with positive symptoms, all got their money back, but highlights the benefit of mass testing and encouraging events to test those not normally tested.

I like the words ‘believe us’ it’s a game changer......they know something they cannot say

I can see the Govt using a limited number of tests there will not just be one. 2 days left in April for Visitect antigen launch, there were interested parties at the CE Mark stage, launch may come with a contract .

2 days and a bit left not long at all

If we go the passport route there is only one LFT antibody test of choice

Last Q&A CK said they were making all tests. So now they will be making the Visitec Antigen test. All tests will be sold it is the only way the pandemic can be controlled and at the moment we are not winning. More testing needed to do that.

If an arrangement is in play, partner or otherwise it would be unwise for the Directors of a company not to declare it to the shareholders unless of course they are not party to the arrangement. Acting in concert is not permitted.

This is the 3rd evening extraordinary large deals have been reported long after closing, one would say unusual, the company silence suggests everything occurring is quite normal

Last buy at 2.55 ever rising

Maybe the big seller just now bailed maybe the new broker lined up some serious money.

I withdraw that idea they would not need a Canadian shell and the law over here is too restricted

I know this is off the wall but Ebers was raising £50m if they have succeeded it would be cheaper than paying 25% royalties in a booming cannabinoid market.

How is this price staying at 2.30ish?

Now on lse trade list 3m+ 21.47 what is going on?

This appears to be the prior from the RNS “ Before moving to Advent, Anne was a Board member and Managing Director of Respivert Ltd, a subsidiary of Janssen Pharmaceuticals (part of Johnson & Johnson, Inc), where she was responsible for leadership and operations of the company, including discovery / development programmes spanning three novel classes of drug for idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and asthma. Is Johnson & Johnson still interested in IPF.

Anne from the Proactive article “ I know about having worked on an asset for IPF in one of my prior companies. I could see it was a great opportunity.” We know there are only 2 IPF drugs out there so is her prior company still looking?

It’s a rising bid with every sale some eager collectors out there

Yeederbaall live trial sport events start today at the Crucible LFTs with the first indoor audience.

One thing we know it will not be the Chinese tests as they take 1/2 hour it is going to be a 10min/15min test that will be used.

Thing about those large buys they are reducing the trading free float as they move to stickier hands. Those trading will find an increasing level of NT on short term dips and will pay ever increasing prices to get back in.